Table 1.
Date | Sample Type | RdRp/Helicase Cycle Threshold Value | Alternate Laboratory Results | Genomic Sequencinga | Serologic Resultsb |
---|---|---|---|---|---|
7/28/2020 | Swab | Detected | VIC12929 | ||
8/15/2020 | Swab | 21 | Not sequenced | ||
8/24/2020 | Swab | Detected | VIC9716 | ||
8/29/2020 | Swab | 26 | Not sequenced | ||
9/5/2020 | Swab | 23 | VIC14804 | ||
9/12/2020 | Swab | 30 | VIC13416 | ||
9/19/2020 | Swab | 32 | Not sequenced | ||
10/13/2020 | Swab | 29 | Detected | VIC16192 | |
10/14/2020 | Sputum | 27c | VIC16281 | ||
10/14/2020 | Serum | IgA, IgG, and total Ab negative | |||
10/18/2020 | Swab | 29 | Not sequenced | ||
10/22/2020 | Swab | 37 | Not sequenced | ||
10/29/2020 | Swab | 30 | Not sequenced | ||
11/16/2020 | Swab | Not detected | … | ||
11/16/2020 | Serum | IgA, IgG, and total Ab negative | |||
11/18/2020 | Swab | Not detected | … |
Sequence identifier in GISAID (https://www.gisaid.org/) and NCBI SRA (https://www.ncbi.nlm.nih.gov/sra).
Serologic assays Euroimmun SARS-CoV-2 S1 IgA and IgG EIA (Euroimmun, Lübeck, Germany) and Wantai SARS-CoV-2 Total Ab EIA (Wantai Biological Pharmacy, Beijing, China).
Viral culture successful on this sample.